Etoricoxib is a COX-2 selective inhibitor from Merck & Co. Current therapeutic indications are: treatment of rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Note that approved indications differ by country.
|
Physical State |
Powder |
|
Packaging Type |
Bags |
|
Packaging Size |
25 Kg |
|
Formula |
C18H15ClN2O2S |
|
Molar mass |
358.842 g/mol |
Price: